Evaluation of a New Tandem Mass Spectrometry Method for Sickle Cell Disease Newborn Screening
International Journal of Neonatal Screening · 26.11.2024 · 10 (4) · 77
DOI: 10.3390/ijns10040077 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 26.11.2024. Verfasst von Céline Renoux und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Biologie Médicale Multi-Sites (LBMMS), Service de Biochimie et Biologie Moléculaire Grand Est, Hospices Civils de Lyon, 69500 Bron, Fr…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In France, sickle cell disease newborn screening (SCD NBS) has been targeted to at-risk regions since 1984, but generalization to the whole population will be implemented from November 2024. Although tandem mass spectrometry (MS/MS) is already used for the NBS of several inherited metabolic diseases, its application for SCD NBS has not been widely adopted worldwide. The aim of this study was to evaluate a dedicated MS/MS kit (Targeted MS/MS Hemo, ZenTech, LaCAR Company, Liege, Belgium) for SCD NBS and to compare the results obtained with those from an NBS reference center using matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) and cation-exchange high-performance liquid chromatography (CE-HPLC, Variant NBS, Biorad Laboratories, Inc., Hercules, CA, USA) as confirmatory method. The MS/MS Hemo kit was used according to the manufacturer’s instructions and performed on a Waters Xevo TQ-D (Waters Corporation, USA). The software provided by the manufacturer was used for the calculation and analysis of peptide signal ratios. Among the 1333 samples, the results of 1324 samples were consistent with the HPLC and/or MALDI-TOF results (1263 FA, 50 FAS, 7 FAC, 1 FAO-Arab, and 3 FS). All the discordant results (one FAS on MS/MS vs. FA in CE-HPLC, one FA on MS/MS vs. FAS in CE-HPLC, seven FS on MS/MS vs. FAS in CE-HPLC) were corrected after modifying the peptide signal ratios thresholds, allowing the MS/MS Hemo kit to achieve near-100% sensitivity and specificity for SCD NBS. In conclusion, the MS/MS Hemo kit appears to be an effective method for SCD NBS, particularly for laboratories already equipped with MS/MS technology. However, these results should be confirmed in a larger cohort including a greater number of positive samples for SCD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratoire de Biologie Médicale Multi-Sites (LBMMS), Service de Biochimie et Biologie Moléculaire Grand Est, Hospices Civils de Lyon, 69500 Bron, France.
- Centre Régional de Dépistage Néonatal Auvergne Rhône-Alpes (CRDN AuRA), 69003 Lyon, France.
- Centre de Référence Constitutif des Maladies Constitutionnelles du Globule Rouge et de l'Erythropoïèse, 69003 Lyon, France.
- Inter-University Laboratory of Human Movement Sciences, LIBM, Universite Claude Bernard Lyon 1, UR 7424, 69622 Villeurbanne, France.
- Laboratoire de Dépistage Périnatal, Pôle de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.
- Service de Chirurgie Gynécologique et Cancérologique-Obstétrique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.
ORCID-Profile: Céline Renoux, Estelle Roland, Philippe Joly, Philippe Connes, David Cheillan
Zitieren
APA
Renoux, C., Roland, E., Ruet, S., Zouaghi, S., Michel, M., Joly, P., Feray, C., Zhao, F., Gavanier, D., Gaucherand, P., Roumieu, F., Cannas, G., Merazga, S., Connes, P., Renom, G., Massardier, J., & Cheillan, D. (2024). Evaluation of a New Tandem Mass Spectrometry Method for Sickle Cell Disease Newborn Screening. International Journal of Neonatal Screening, 10(4), 77. https://doi.org/10.3390/ijns10040077
Vancouver
Renoux C, Roland E, Ruet S, Zouaghi S, Michel M, Joly P, et al. Evaluation of a New Tandem Mass Spectrometry Method for Sickle Cell Disease Newborn Screening. International Journal of Neonatal Screening. 2024;10(4):77. doi:10.3390/ijns10040077
BibTeX
@article{Renoux2024,
author = {Renoux, Céline and Roland, Estelle and Ruet, Séverine and Zouaghi, Sarah and Michel, Marie and Joly, Philippe and Feray, Cécile and Zhao, Fanny and Gavanier, Déborah and Gaucherand, Pascal and Roumieu, Fanny and Cannas, Giovanna and Merazga, Salima and Connes, Philippe and Renom, Gilles and Massardier, Jérôme and Cheillan, David},
title = {Evaluation of a New Tandem Mass Spectrometry Method for Sickle Cell Disease Newborn Screening},
journal = {International Journal of Neonatal Screening},
year = {2024},
volume = {10},
number = {4},
pages = {77},
doi = {10.3390/ijns10040077}
}
EUVIMED